Clinical research of insulin glargine U300 basal‐bolus therapy and insulin degludec/aspart co‐formulation in type 2 diabetes mellitus: A real world experience

Aims Insulin degludec/aspart (IDegAsp) and insulin glargine U300 (IGlarU300) have recently emerged as popular new‐generation insulin analogues. The aim of this real‐life study was to investigate the patient profiles in which IGlarU300 and IDegAsp were preferred and the insulin combinations after whi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of clinical practice (Esher) 2021-09, Vol.75 (9), p.e14377-n/a, Article 14377
Hauptverfasser:	Kisioglu, Savas Volkan, Demir, Ahmet Suat, Tufekci, Damla, Emur Gunay, Yasemin, Coskun, Hulya, Ucuncu, Ozge, Nuhoglu, Irfan, Kocak, Mustafa, Karakullukcu, Serdar, Ersoz, Halil Onder
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood glucose Body mass index Body weight Body weight gain Diabetes mellitus (non-insulin dependent) General & Internal Medicine Glucose Hypoglycemia Insulin Life Sciences & Biomedicine Medicine, General & Internal Patients Pharmacology & Pharmacy Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!